The results suggest that chronic exposure to traffic-related air pollution is associated with increases in biomarkers of astroglial reactivity and inflammation, particularly in women.

On Saturday 3 October, we're opening the doors of the PRBB. Come inside the building, visit the laboratories and scientific facilities, and find out what we're researching, how we do it, and who's behind it.

INTRODUCTION Blood biomarkers like phosphorylated tau (p-tau)217 offer high diagnostic accuracy for Alzheimer's disease (AD) but face implementation challenges in low-prevalence settings. We evaluat...

YouTube video by AD-RIDDLE

¿Puede la Inteligencia Artificial ayudarnos a cambiar el futuro del Alzheimer? En el Grupo de Investigación en IA y Datos de Salud del BBRC, liderado por el Dr. Joaquín Dopazo, utilizamos inteligencia artificial y análisis avanzado de datos para transformar grandes volúmenes de información biomédica en conocimiento útil para la investigación. Este enfoque nos permite comprender mejor cómo se desarrolla el Alzheimer, identificar señales tempranas de la enfermedad y avanzar hacia una medicina más personalizada y preventiva. Descubre más en este nuevo episodio de Conoce la investigación. ______ Can Artificial Intelligence help change the future of Alzheimer's? At the BBRC's AI and Health Data Research Group, led by Dr. Joaquín Dopazo, we use AI and advanced data analysis to transform large-scale biomedical data into knowledge that drives Alzheimer's research. This approach helps us better understand how the disease develops, identify its earliest biological signals, and advance more personalised and preventive medicine. Discover more in this new episode of Meet the Research. More information Visit our web: https://fpmaragall.org/ Visit our blog: http://blog.fpmaragall.org/ Follow us on: Facebook: / fpmaragall X: https://x.com/fpmaragall / https://x.com/BarcelonaBeta Linkedin: / pasqual-maragall-foundation Instagram: / fpmaragall Bluesky: https://bsky.app/profile/barcelonabeta.bsky.social

Cogswell et al. show that plasma and PET biomarkers for Alzheimer's disease provide useful information about when cognitive decline is likely to begin, and

A large multicenter proteomics study identified blood biomarkers that distinguish Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, supporting biomarker-based differential di...

The study identifies protein signatures specific to Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and integrates them into a single quantitative biomarker panel.

Despite their detrimental health effects, disease loci persist in human populations. This study shows that disease-risk alleles are generally associated with reduced longevity and increased fertility,...

Despite their detrimental health effects, disease loci persist in human populations. This study shows that disease-risk alleles are generally associated with reduced longevity and increased fertility,...